Ciprofloxacin hydrochloride and Bladder transitional cell carcinoma - a phase IV clinical study of FDA data
We study 1,851 people who have side effects when taking Ciprofloxacin hydrochloride. Bladder transitional cell carcinoma is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Minoxidil and have High blood pressure.
The phase IV clinical study analyzes which people take Ciprofloxacin hydrochloride and have Bladder transitional cell carcinoma. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,851 people reported to have side effects when taking Ciprofloxacin hydrochloride.
Among them, 30 people (1.62%) have Bladder transitional cell carcinoma.
What is Ciprofloxacin hydrochloride?
Ciprofloxacin hydrochloride has active ingredients of ciprofloxacin hydrochloride. It is used in urinary tract infection. Currently, eHealthMe is studying from 2,504 Ciprofloxacin hydrochloride users.
What is Bladder transitional cell carcinoma?
Bladder transitional cell carcinoma (types of bladder cancer) is found to be associated with 466 drugs and 220 conditions by eHealthMe. Currently, we are studying 3,140 people who have Bladder transitional cell carcinoma.
Number of Ciprofloxacin hydrochloride and Bladder transitional cell carcinoma reports submitted per year:
Time on Ciprofloxacin hydrochloride when people have Bladder transitional cell carcinoma *:
- < 1 month: 0.0 %
- 1 - 6 months: 85.71 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 14.29 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Bladder transitional cell carcinoma when taking Ciprofloxacin hydrochloride *:
- female: 100 %
- male: 0.0 %
Age of people who have Bladder transitional cell carcinoma when taking Ciprofloxacin hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Ciprofloxacin hydrochloride *:
- Valsartan: 30 people, 100.00%
- Ibuprofen: 30 people, 100.00%
- Prednisolone: 30 people, 100.00%
- Nystatin: 30 people, 100.00%
- Minoxidil: 30 people, 100.00%
- Azithromycin: 29 people, 96.67%
- Ampicillin Sodium: 28 people, 93.33%
- Cefpodoxime Proxetil: 28 people, 93.33%
- Clindamycin Hydrochloride: 28 people, 93.33%
- Doxazosin Mesylate: 28 people, 93.33%
Common side effects people have besides Bladder transitional cell carcinoma *:
- Second Primary Malignancy (after getting cure a cancer, a new cancer development): 4 people, 13.33%
Common conditions people have *:
- High Blood Pressure: 30 people, 100.00%
- Cardiac Failure: 21 people, 70.00%
* Approximation only. Some reports may have incomplete information.
Do you take Ciprofloxacin hydrochloride and have Bladder transitional cell carcinoma?Check whether Bladder transitional cell carcinoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Ciprofloxacin hydrochloride side effects by duration, gender and age:
- Ciprofloxacin hydrochloride side effects (2,504 reports)
Bladder transitional cell carcinoma treatments and more:
- Bladder transitional cell carcinoma (3,140 reports)
Common drugs associated with Bladder transitional cell carcinoma:
- Actos: 703 reports
- Metformin: 252 reports
- Methotrexate: 173 reports
- Humira: 145 reports
- Remicade: 124 reports
- Aspirin: 121 reports
All the drugs that are associated with Bladder transitional cell carcinoma:
- Bladder transitional cell carcinoma (466 drugs)
Common conditions associated with Bladder transitional cell carcinoma:
- Type 2 diabetes: 668 reports
- Diabetes: 143 reports
- Rheumatoid arthritis: 138 reports
- High blood pressure: 134 reports
All the conditions that are associated with Bladder transitional cell carcinoma:
- Bladder transitional cell carcinoma (220 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ciprofloxacin hydrochloride (the active ingredients of Ciprofloxacin hydrochloride) and Ciprofloxacin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cytarabine and Epstein-Barr Virus Associated Lymphoproliferative Disorder - 2 seconds ago
- Avalide and Saphris drug interaction - 21 seconds ago
- Solu-Cortef and Vision Blurred - 22 seconds ago
- Calciparine and Clopra drug interaction - 26 seconds ago
- Metoprolol Tartrate and Poor Quality Sleep - 38 seconds ago
- Depo-Provera and Platelet Count Increased - 53 seconds ago
- Movantik and Zofran drug interaction - a minute ago
- Duoneb and Lacunar Infarction - a minute ago
- Probiotic and Dexedrine drug interaction - a minute ago
- St. John'S Wort and Zestril drug interaction - a minute ago